# Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis

> **NCT00343850** · PHASE3 · COMPLETED · sponsor: **University of Chicago** · enrollment: 30 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Asacol (mesalamine)

## Key facts

- **NCT ID:** NCT00343850
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343850, "Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00343850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*